nodes	percent_of_prediction	percent_of_DWPC	metapath
Amrinone—TNF—psoriasis	0.876	1	CbGaD
Amrinone—TNF—Allograft Rejection—IL22—psoriasis	0.00414	0.0334	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IL23R—psoriasis	0.00331	0.0267	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IL23A—psoriasis	0.00281	0.0227	CbGpPWpGaD
Amrinone—TNF—EBV LMP1 signaling—CCL20—psoriasis	0.00265	0.0214	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL15—psoriasis	0.00261	0.0211	CbGpPWpGaD
Amrinone—TNF—Canonical NF-kappaB pathway—TNFAIP3—psoriasis	0.00208	0.0168	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL13—psoriasis	0.00184	0.0148	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—IL17A—psoriasis	0.00174	0.0141	CbGpPWpGaD
Amrinone—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—psoriasis	0.00164	0.0133	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—IL12B—psoriasis	0.00162	0.0131	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL12B—psoriasis	0.00157	0.0127	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—RUNX3—psoriasis	0.00134	0.0108	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IL17A—psoriasis	0.00132	0.0106	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—CRP—psoriasis	0.00128	0.0103	CbGpPWpGaD
Amrinone—TNF—TNF receptor signaling pathway —TNFRSF1B—psoriasis	0.00124	0.01	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IL12B—psoriasis	0.00122	0.00987	CbGpPWpGaD
Amrinone—TNF—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.00122	0.00984	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—SERPINB8—psoriasis	0.0012	0.00972	CbGpPWpGaD
Amrinone—TNF—TNF receptor signaling pathway —TNFAIP3—psoriasis	0.00119	0.00964	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL10—psoriasis	0.00115	0.00929	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL4—psoriasis	0.00112	0.00904	CbGpPWpGaD
Amrinone—TNF—Transcription factor regulation in adipogenesis—LEP—psoriasis	0.00112	0.009	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.00103	0.0083	CbGpPWpGaD
Amrinone—TNF—Canonical NF-kappaB pathway—NFKBIA—psoriasis	0.001	0.0081	CbGpPWpGaD
Amrinone—TNF—EBV LMP1 signaling—NFKBIA—psoriasis	0.001	0.0081	CbGpPWpGaD
Amrinone—TNF—Transcription factor regulation in adipogenesis—PPARG—psoriasis	0.000972	0.00784	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—CAT—psoriasis	0.000927	0.00748	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—HLA-DRB1—psoriasis	0.000927	0.00748	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—CARM1—psoriasis	0.000857	0.00692	CbGpPWpGaD
Amrinone—TNF—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.00085	0.00686	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—CXCL8—psoriasis	0.000833	0.00673	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—HLA-C—psoriasis	0.000784	0.00633	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—IL13—psoriasis	0.000779	0.00629	CbGpPWpGaD
Amrinone—TNF—amb2 Integrin signaling—ICAM1—psoriasis	0.000776	0.00627	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TNFRSF1B—psoriasis	0.000766	0.00618	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—REL—psoriasis	0.000754	0.00609	CbGpPWpGaD
Amrinone—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—NFKBIA—psoriasis	0.000751	0.00607	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—TYK2—psoriasis	0.000745	0.00601	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—IL17A—psoriasis	0.000717	0.00579	CbGpPWpGaD
Amrinone—TNF—EBV LMP1 signaling—CXCL8—psoriasis	0.000715	0.00577	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—TNFRSF1B—psoriasis	0.000712	0.00575	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—IFNG—psoriasis	0.000697	0.00563	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—NOS2—psoriasis	0.000686	0.00554	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—NFKBIA—psoriasis	0.000686	0.00554	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—TNFAIP3—psoriasis	0.000686	0.00554	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—psoriasis	0.000684	0.00552	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IFNG—psoriasis	0.000677	0.00546	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—IL12B—psoriasis	0.000667	0.00538	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—CD4—psoriasis	0.000654	0.00528	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—HLA-E—psoriasis	0.000651	0.00525	CbGpPWpGaD
Amrinone—PDE3A—Platelet homeostasis—NOS2—psoriasis	0.000641	0.00517	CbGpPWpGaD
Amrinone—TNF—Canonical NF-kappaB pathway—NFKB1—psoriasis	0.00064	0.00517	CbGpPWpGaD
Amrinone—TNF—EBV LMP1 signaling—NFKB1—psoriasis	0.00064	0.00517	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—NFKBIA—psoriasis	0.00062	0.005	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—CAT—psoriasis	0.000596	0.00481	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—CRP—psoriasis	0.000582	0.0047	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000573	0.00462	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—APOE—psoriasis	0.000569	0.0046	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—TYK2—psoriasis	0.000562	0.00453	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—NFKBIA—psoriasis	0.000557	0.00449	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—psoriasis	0.000557	0.00449	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—psoriasis	0.000552	0.00446	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—IL4—psoriasis	0.000548	0.00442	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—IL12B—psoriasis	0.000543	0.00439	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000539	0.00435	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—ICAM1—psoriasis	0.000535	0.00432	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IFNG—psoriasis	0.000526	0.00425	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—STAT3—psoriasis	0.000522	0.00421	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—CD4—psoriasis	0.000508	0.0041	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—psoriasis	0.000504	0.00407	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—HLA-A—psoriasis	0.000496	0.004	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—TNFAIP3—psoriasis	0.000493	0.00398	CbGpPWpGaD
Amrinone—TNF—amb2 Integrin signaling—NFKB1—psoriasis	0.000492	0.00397	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—IL10—psoriasis	0.000488	0.00394	CbGpPWpGaD
Amrinone—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—NFKB1—psoriasis	0.00048	0.00387	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—IL4—psoriasis	0.000474	0.00383	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—CAT—psoriasis	0.000474	0.00382	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—CRP—psoriasis	0.000473	0.00382	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—IL6—psoriasis	0.000468	0.00378	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—HLA-B—psoriasis	0.000464	0.00374	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—HCAR2—psoriasis	0.000461	0.00372	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—IL13—psoriasis	0.000452	0.00365	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000442	0.00357	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—HCAR2—psoriasis	0.000439	0.00354	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—NFKB1—psoriasis	0.000438	0.00353	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—ICAM1—psoriasis	0.000435	0.00351	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—HLA-A—psoriasis	0.00043	0.00347	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—IL12B—psoriasis	0.000424	0.00342	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—HCAR2—psoriasis	0.000419	0.00338	CbGpPWpGaD
Amrinone—TNF—Transcription factor regulation in adipogenesis—IL6—psoriasis	0.000416	0.00336	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	0.000413	0.00334	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—NFKBIA—psoriasis	0.000412	0.00332	CbGpPWpGaD
Amrinone—TNF—FAS pathway and Stress induction of HSP regulation—JUN—psoriasis	0.000411	0.00332	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—JUN—psoriasis	0.000411	0.00332	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—LEP—psoriasis	0.000409	0.0033	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—IFNG—psoriasis	0.000407	0.00328	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—APOE—psoriasis	0.000401	0.00324	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—HCAR2—psoriasis	0.000398	0.00322	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—NFKB1—psoriasis	0.000395	0.00319	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—STAT3—psoriasis	0.000393	0.00317	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—HLA-DRB1—psoriasis	0.000393	0.00317	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—IFNG—psoriasis	0.000389	0.00314	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—PPARG—psoriasis	0.000385	0.00311	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	0.000384	0.0031	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000382	0.00308	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—CRP—psoriasis	0.000376	0.00304	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000368	0.00297	CbGpPWpGaD
Amrinone—TNF—TNF receptor signaling pathway —NFKB1—psoriasis	0.000368	0.00297	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—SOCS1—psoriasis	0.000365	0.00295	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—IL6—psoriasis	0.000364	0.00294	CbGpPWpGaD
Amrinone—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	0.000357	0.00288	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—PPARG—psoriasis	0.000357	0.00288	CbGpPWpGaD
Amrinone—TNF—Apoptosis—NFKBIA—psoriasis	0.000356	0.00287	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—NFKB1—psoriasis	0.000355	0.00287	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL6—psoriasis	0.000353	0.00285	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—ITGAL—psoriasis	0.00035	0.00282	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—SOCS1—psoriasis	0.000346	0.00279	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—ICAM1—psoriasis	0.000346	0.00279	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—IL4—psoriasis	0.000344	0.00278	CbGpPWpGaD
Amrinone—TNF—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.000344	0.00278	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—NFKB1—psoriasis	0.000339	0.00273	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—JUN—psoriasis	0.000336	0.00271	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000334	0.00269	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—psoriasis	0.000331	0.00267	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—IFNG—psoriasis	0.000331	0.00267	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—NFKBIA—psoriasis	0.000331	0.00267	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—psoriasis	0.000328	0.00265	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—NFKB1—psoriasis	0.000323	0.00261	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—NFKB1—psoriasis	0.000319	0.00257	CbGpPWpGaD
Amrinone—TNF—amb2 Integrin signaling—IL6—psoriasis	0.000309	0.00249	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—NFKBIA—psoriasis	0.000305	0.00246	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—psoriasis	0.000294	0.00237	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—LEP—psoriasis	0.000291	0.00235	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—STAT3—psoriasis	0.000291	0.00235	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—IFNG—psoriasis	0.000287	0.00231	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—JUN—psoriasis	0.000286	0.00231	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—IL10—psoriasis	0.000283	0.00228	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—NFKB1—psoriasis	0.000275	0.00222	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IL6—psoriasis	0.000275	0.00222	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—ICAM1—psoriasis	0.000273	0.00221	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—NOS2—psoriasis	0.000271	0.00219	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—LEP—psoriasis	0.000269	0.00217	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—CXCL8—psoriasis	0.000267	0.00215	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—IFNG—psoriasis	0.000263	0.00212	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—NFKB1—psoriasis	0.000263	0.00212	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—IL6—psoriasis	0.000248	0.002	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—HCAR2—psoriasis	0.000247	0.002	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—NFKB1—psoriasis	0.000243	0.00197	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—CCL20—psoriasis	0.00024	0.00193	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—NFKBIA—psoriasis	0.000238	0.00192	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—STAT3—psoriasis	0.000236	0.00191	CbGpPWpGaD
Amrinone—TNF—Apoptosis—JUN—psoriasis	0.000236	0.0019	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—HCAR2—psoriasis	0.000235	0.0019	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—PPARG—psoriasis	0.000235	0.00189	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—JUN—psoriasis	0.000233	0.00188	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—CCL20—psoriasis	0.000228	0.00184	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—psoriasis	0.000227	0.00183	CbGpPWpGaD
Amrinone—TNF—Apoptosis—NFKB1—psoriasis	0.000227	0.00183	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—NFKB1—psoriasis	0.000225	0.00181	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.00022	0.00177	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—JUN—psoriasis	0.000219	0.00177	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—NFKB1—psoriasis	0.000219	0.00177	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—CCL20—psoriasis	0.000218	0.00176	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—CXCL8—psoriasis	0.000217	0.00175	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—VEGFA—psoriasis	0.000216	0.00175	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TAGAP—psoriasis	0.000215	0.00173	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—IL6—psoriasis	0.000213	0.00172	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—NFKB1—psoriasis	0.000211	0.0017	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—IFNG—psoriasis	0.000208	0.00168	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—CCL20—psoriasis	0.000207	0.00167	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—psoriasis	0.000204	0.00165	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TAGAP—psoriasis	0.000204	0.00165	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—JUN—psoriasis	0.000202	0.00163	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—NFKB1—psoriasis	0.000194	0.00157	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CARM1—psoriasis	0.000194	0.00156	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—CXCL8—psoriasis	0.000193	0.00156	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—TP53—psoriasis	0.000189	0.00152	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000184	0.00149	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—IL6—psoriasis	0.000173	0.0014	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—psoriasis	0.00017	0.00137	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—TP53—psoriasis	0.000164	0.00132	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—JUN—psoriasis	0.000158	0.00127	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—psoriasis	0.000156	0.00126	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000155	0.00125	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	0.000152	0.00123	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—STAT3—psoriasis	0.000144	0.00116	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—JUN—psoriasis	0.000144	0.00116	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—NOS2—psoriasis	0.000144	0.00116	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	0.000141	0.00114	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000138	0.00112	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—IL6—psoriasis	0.000137	0.00111	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—JUN—psoriasis	0.000136	0.00109	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—IL6—psoriasis	0.000133	0.00107	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—NFKB1—psoriasis	0.00013	0.00105	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CCL20—psoriasis	0.000129	0.00104	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000126	0.00101	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000122	0.000987	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CCL20—psoriasis	0.000122	0.000987	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—IL6—psoriasis	0.000122	0.000985	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—TP53—psoriasis	0.000119	0.000958	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000118	0.00095	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—IL6—psoriasis	0.000109	0.000877	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.000107	0.000862	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—IL6—psoriasis	0.000101	0.000811	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—psoriasis	9.54e-05	0.00077	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	9.53e-05	0.000769	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—LEP—psoriasis	9.26e-05	0.000747	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—TP53—psoriasis	8.95e-05	0.000722	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—IL6—psoriasis	8.69e-05	0.000701	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—VEGFA—psoriasis	8.31e-05	0.000671	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.07e-05	0.000652	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—PPARG—psoriasis	8.06e-05	0.000651	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—SOCS1—psoriasis	7.08e-05	0.000571	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—TYK2—psoriasis	7.06e-05	0.00057	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—TYK2—psoriasis	6.75e-05	0.000545	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—SOCS1—psoriasis	6.73e-05	0.000543	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—CXCL8—psoriasis	6.47e-05	0.000522	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—TYK2—psoriasis	6.42e-05	0.000518	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—TP53—psoriasis	6.28e-05	0.000507	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—CXCL8—psoriasis	6.15e-05	0.000497	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—CXCL8—psoriasis	5.88e-05	0.000474	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—CXCL8—psoriasis	5.59e-05	0.000451	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—NFKB1—psoriasis	5.5e-05	0.000444	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—LEP—psoriasis	5.22e-05	0.000422	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—APOE—psoriasis	5.22e-05	0.000422	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—VEGFA—psoriasis	5e-05	0.000403	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—LEP—psoriasis	4.97e-05	0.000401	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—APOE—psoriasis	4.97e-05	0.000401	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—STAT3—psoriasis	4.95e-05	0.000399	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NFKBIA—psoriasis	4.87e-05	0.000393	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NFKBIA—psoriasis	4.63e-05	0.000374	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TYK2—psoriasis	3.99e-05	0.000322	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TYK2—psoriasis	3.79e-05	0.000306	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CXCL8—psoriasis	3.47e-05	0.00028	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—IL6—psoriasis	3.45e-05	0.000279	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CXCL8—psoriasis	3.3e-05	0.000266	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—IL6—psoriasis	3.3e-05	0.000266	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—JUN—psoriasis	3.23e-05	0.00026	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—IL6—psoriasis	3.14e-05	0.000253	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NFKB1—psoriasis	3.11e-05	0.000251	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—JUN—psoriasis	3.07e-05	0.000248	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NFKB1—psoriasis	2.95e-05	0.000238	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—VEGFA—psoriasis	2.82e-05	0.000228	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—STAT3—psoriasis	2.79e-05	0.000225	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—VEGFA—psoriasis	2.68e-05	0.000216	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—STAT3—psoriasis	2.65e-05	0.000214	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TP53—psoriasis	2.13e-05	0.000172	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TP53—psoriasis	2.03e-05	0.000164	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IL6—psoriasis	1.95e-05	0.000157	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IL6—psoriasis	1.85e-05	0.00015	CbGpPWpGaD
